Blood collection tube is a plastic
or glass tube that is without any infection or contamination. These
tubes also have a closure, which is evacuated in order to build a vacuum
in the interior of the tube, which in turn enables drawing an exact
liquid volume from the patient. These tubes are primarily used to
collect blood samples. However, they can also be used to collect urine
samples as well as serum separator tubes. The North American market for
blood collection tubes is gaining traction from a number of factors
including the escalating demand from aging population for blood products
and increasing number of complex surgical procedures.
The blood collection tubes market in
North America was worth US$300.8 mn in 2014, which is estimated to reach
a valuation of US$632.1 mn by 2023, expand at a robust CAGR of 8.6%
during the forecast period of 2015 to 2023. The prosperity of this
market can be attributed to the vast opportunities available for the
players in the form of advanced screening tests, implementation of new
blood collection techniques, and advent of automation in the process of
collection of blood. These are some of the key factors anticipated to
cater a significant demand in the North America market for blood
collection tubes across North American countries such as the U.S. and
Canada. On the other hand, stringent regulatory guidelines and
healthcare policies will also reflect positively on the market during
the forecast period as manufacturers are frequently coming up with new
and safer technologies in order to collect blood. In addition to that,
North America makes for a developed region, and thereby has high level
of awareness among the consumers such as hospitals and diagnostic
centers. This factor, as well as the subsidies offered by the government
in the U.S. and Canada and advancements in blood collection
technologies is expected to favor the market in a long-term.
Serum Separating Tubes In-Demand Segment
Based on product type, the global blood
collection tubes market has been segmented into herapin tubes, plasma
separation tube, EDTA tubes, serum separating tubes, rapid serum tubes,
and others. Among these, the serum separating tubes segment accounted
for 39.6% shares of the market in 2014, which was a result of
utilization of diagnosis purposes across North America and utilization
of diagnosis purposes across North America and increasing number of
serum samples collected. Serum separating tubes utilize a particular gel
that helps in separating blood cells from serum, and also contains
particles that cause blood to clot easily. Serum is used to detect the
presence of a particular antibody, antigen, hormone, and exogenous
substances. Apart from that, the segment of rapid serum tubes is
anticipated to increase at a higher rate during the forecast period,
which is a result of advent of advanced technologies and incremented
efficiency offered by the product.
The U.S. Most Lucrative Market by a Country-mile
The U.S. is the most lucrative country in
the North America blood collection tubes market, accounting for 84.6%
of the demand, which is primarily a reflection of increasing geriatric
population along with the prevalence of various diseases. In addition to
that, the increasing government initiatives in the country of the U.S.
is expected to drive this market further. For example, introduction of
patient protection affordable care act (PPACA) in March 2010 provides
healthcare coverage to more than 94% of Americans. Canada is the second
most profitable country in the North America blood collection tubes
market.
The North America blood collection tubes
market is consolidated with a Becton Dickinson and Company being the
pioneer and industry leader with 95% of the market in 2014. With a
strong product portfolio of pre-analytical systems, BD is expected to
maintain its stronghold in the near future. Terumo Corporation and
Qiagen N.V. are some of the other prominent companies operating in this
market.
No comments:
Post a Comment